PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Magway is a sustainable and reliable transport solution that aims to improve air quality and congestion. It is the winner of Innovate UK grant and has been recognised as a top 100 Global Startup. Magway is planning initial revenue opportunity from short routes around airports. Moreover, the company has an agreement in place with a leading engineering firm to plan implementation. It is a high-impact investment opportunity that plans to generate revenues by expanding internationally, transforming delivery around urban centres in the UK, and providing secure goods handling solutions for airports. With the proceeds, Magway aims to accelerate development, register further patents, and build the team.
days to go:
Expired
investment:
£1,344,460
ShareProperty is a property crowdfunding platform that allows you, the investor to select your investment according to your own risk profile and required rate of return. ShareProperty allows you to build and manage your own property portfolio, hold your investment to term or resell on the ShareProperty trading exchange.
days to go:
Expired
investment:
£149,002
Next-generation wellbeing analytics for individuals and organisations – boosts happiness and productivity
days to go:
Expired
investment:
£768,597
Clooper is a property management platform. The company argues that 86% of private landlords in the UK manage their properties themselves, with many finding it time-consuming and stressful. Clooper seeks to solve this problem with a property management platform that connects landlords, tenants, trade services, and homeowners to facilitate easy transactions between them. It aims to be a significant contender in the £11 billion property management platform. The company points out that Paul Rothwell of Empire, a large residential landlord in England, has pledged £200,000 of investment to the company. Clooper aims to make move-ins quicker, repairs faster, and payments easier in the wake of Covid-19 which is fuelling the adoption of online services in the UK. The company will use the investment to hire key recruits, operationalise mobile apps, boost marketing, and enhance sales and operations.
days to go:
Expired
investment:
£409,847
Improving urban mobility by offering a bike sharing service to reduce congestion and pollution whilst increasing physical activity. cycle.land has recently entered a partnership with Youon, the largest bike share company in China, to deliver their services all over Europe. The fleet will consist of regular bicycles, in addition to e-bikes, e-scooters and e-cars. cycle.land has also worked in conjunction with local councils, Transport for London and local boroughs to introduce dock less mobility companies in the UK.
days to go:
Expired
investment:
£331,963
Carbaya are an easy way to buy and sell a used car. They are an online peer to peer marketplace that puts convenience, value and trust back into the used car industry, offering buyers and sellers better value for their car and money. The marketplace will serve all used cars less than 6 year old and with less than 60,000 miles and once a sale is made they will drop the car off, washed and with a full tank of petrol to the buyer.
days to go:
Expired
investment:
£351,273
